BIO Protocol V2 Launchpad dey spark DeSci market revival
BIO Protocol, wey be leader for decentralized science (DeSci), don launch im V2 upgrade wey dey bring new Launchpad, BioXP points system, staking wit veBIO, and automated liquidity engines. After im January launch, BIO Protocol price drop 95% because high FDV and missing features, but di V2 release help double im market cap pass $200 million and over 100 million tokens staked within one week. Di upgrade lower FDV to $205,000, give fixed-price launches for new projects, and dey measure user engagement through BioXP and veBIO incentives. Di new liquidity engine dey collect 1% from secondary trades, to fund research and reward token holders. Clinical trials for VitaRNA and VitaFAST dey happen for UAE and partnership wit Pfizer show real DeSci uses. The upcoming Launchpad 2.0 and Founding LP Program dey plan to onboard 10–20 low-cap projects across Base and Solana, show say investors dey interested again for DeSci and fit bring short-term trading benefit and long-term ecosystem growth.
Bullish
Di launch wey dem do for BIO Protocol V2 plus di new Launchpad don fix d problems wey dey for utility before and e don already make plenty on-chain activities, plus market value don double. Dem introduce BioXP points, veBIO staking, plus one liquidity engine wey be like d tokenomics upgrades wey dey work well for other DeFi projects, e dey push both short-term trading and long-term holder commitment. Real-life DeSci cases like VitaRNA clinical trials and their Pfizer partnership add real value and make investors trust di thing more. Di Launchpad 2.0 wey dey come and Founding LP Program go help growth even more as dem go bring new projects join Base and Solana. All these factors show say d thing get bright future, e fit make trading volume high and keep market interest strong.